FT LAUDERDALE, FL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Biostasis Technologies Inc, founded in 2022, is a small nonprofit in the Medical Research sector that reported $937K in total revenue in fiscal year 2025. Expenses of $835K left a modest 11% surplus.
To conduct and support scientific research and education focusing primarily on hypothermic tissue stabilization for organ preservation brain banking anatomical donation and human biostasis.
The organization conducts experimental and theoretical research aimed at improving hypothermic tissue stabilization. Activities include development and implementation of protocols and clinical...
The organization conducts experimental and theoretical research aimed at improving hypothermic tissue stabilization. Activities include development and implementation of protocols and clinical standards providing education and training services for medical professionals preparation and dissemination of reports and other publications and coordinating the development and formation of regional organizations to deliver hypothermic tissue stabilization services. Current year accomplishments include: 1 assisted on two international biostasis cases; 2 completed manuscript of a forthcoming non-fiction book about biostasis; 3 increased subscribers to the Biostasis Standard an online scientific journal by 39%;4 conducted bi-annual training for clinical staff contractors and other attendees; 5 continued development of new cooling technologies; 6 completion and introduction of a liquid ventilation device capable of mitigating ischemic brain injury by inducing rapid cooling immediately after cardiac arrest; and 7 delivery of scientific presentations at several public conferences.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $937,020 | $868,209 | +0.1% |
| Expenses | $835,192 | $848,980 | 0.0% |
| Net Income | $101,828 | $19,229 | +4.3% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Michael Benjamin | Secretary Treasurer | 40.00 |
Officer
|
$120,677 | $0 | $120,677 |
| Houston Westfall | Director | 4.00 |
Director
|
$0 | $0 | $0 |
| Carrie Radomski | Director | 4.00 |
Director
|
$0 | $0 | $0 |
| Benjamin Best | Director | 4.00 |
Director
|
$0 | $0 | $0 |
| Aschwin de Wolf | President | 40.00 |
Officer
|
$0 | $0 | $0 |
| Keegan Macintosh | Director | 4.00 |
Director
|
$0 | $0 | $0 |
| Max More | Director of Communications | 40.00 |
Highest
|
$106,436 | $4,257 | $110,693 |
| Lauren Fosco | Chief Operating Officer | 40.00 |
Highest
|
$132,429 | $3,857 | $136,286 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $937,020 | $835,192 | $155,286 | $101,828 |
| 2024 | $868,209 | $848,980 | $396,423 | $19,229 |
| 2023 | $559,929 | $537,100 | $170,767 | $22,829 |
| 2022 | $169,164 | $158,164 | $216,774 | $11,000 |
Compare Biostasis Technologies Inc with other nonprofits in Florida and across the country.